CURE’s metastatic breast cancer page features the latest cancer news and updates on metastatic breast cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in metastatic breast cancer.
June 1st 2023
Who would have thought that a small dinosaur toy helped give me the strength to fight metastatic breast cancer?
May 26th 2023
Integrating a metastatic breast cancer diagnosis with the life you have takes time and effort.
May 10th 2023
I'm thankful that I spoke up about my bone pain related to cancer metastases.
April 18th 2023
Is it always one or the other? Can good news in one person’s cancer experience do good for the community?
April 9th 2023
When I was first diagnosed, I wasn’t sure what kind of support to ask for, but now I’m thankful to have many wonderful forms of support around me.
April 5th 2023
HER3-DXd proved to be safe and efficacious in treating patients with HER3-expressing metastatic breast cancer, recent study results showed.
April 4th 2023
Sometimes, hundreds of pages of cancer information still just doesn’t connect with the person who needs it.
March 20th 2023
Pre- and post-menopausal patients with locally advanced or metastatic ER+/HER2- breast cancer with an ESR1 mutation are eligible to participate in the next round of Fablyn’s upcoming clinical trial.
March 1st 2023
I didn’t think that I’d lose my hair again after starting my latest breast cancer treatment, but I did — and with that hair loss came both new and familiar feelings.
February 28th 2023
Research backs up my personal experience regarding aging and cancer.
February 13th 2023
Orserdu demonstrated improved outcomes and quality of life for certain patients with metastatic breast cancer.
February 10th 2023
I’m working through one of the toughest times of my life. Perserverance is one of the many things that cancer has taught me.
February 9th 2023
The FDA approval of Trodelvy for patients with HR-positive, HER2-negative metastatic breast cancer provides patients with another treatment option after hormone therapy and standard chemotherapy.
February 9th 2023
After I was diagnosed with stage 4 breast cancer, clinicians told me I wouldn’t make it to my 35th birthday, but I recently did — and look forward to celebrating many more.
February 6th 2023
The new year brings reflection on living fully with cancer.
February 3rd 2023
The Food and Drug Administration approved Trodelvy for patients with pretreated, unresectable HR-positive, HER2-negative metastatic breast cancer.
January 18th 2023
Last month, I learned that the treatment for my metastatic breast cancer stopped working, but was thrilled to learn about Enhertu — a new drug for a new subset of patients with breast cancer — as the next line of therapy.
January 12th 2023
After I was diagnosed with cancer, some people “ghosted” me, but my dog, Iris, never did.
December 31st 2022
As we enter 2023, I’m looking at life a bit differently, and will prioritize things that make me happy.
December 28th 2022
Having cancer care denied or delayed is not a harmless situation when your life is on the line.
December 23rd 2022
After being diagnosed with cancer, my love for December is not just Christmas.
December 13th 2022
Improvements may not be seen right away, but patients with non-metastatic breast cancer should stay compliant to practicing yoga to possibly improve quality of life, according to an expert.
December 6th 2022
I’ve realized that my forgetfulness and business of working multiple jobs through cancer might have actually helped my mental health.
November 29th 2022
Watch Dr. Leif Ellisen, Dr. Dejan Juric, Dr. Beverly Moy and Natasha Mmeje answer questions about unmet needs during the CURE Educated Patient Metastatic Breast Cancer Summit.
November 28th 2022
Watch Dr. Beverly Moy, from Massachusetts General Hospital, discuss addressing breast cancer disparity during the CURE Educated Patient Metastatic Breast Cancer Summit.
November 27th 2022
Watch Dr. Dejan Juric, from Massachusetts General Hospital, discuss therapeutic resistance during the CURE Educated Patient Metastatic Breast Cancer Summit.
November 26th 2022
Watch Dr. Aditya Bardia, Dr. Arielle J. Medford and Dr. Neelima Vidula answer questions about HER2 and triple-negative disease during the CURE Educated Patient Metastatic Breast Cancer Summit.
November 25th 2022
Watch Dr. Neelima Vidula, from Massachusetts General Hospital, discuss the management of triple-negative disease during the CURE Educated Patient Metastatic Breast Cancer Summit.
Pre- and Post-Surgical Keytruda Boosts Outcomes in Early NSCLC
An App Improved Anxiety, Depression Symptoms in Patients With Cancer
Imjudo-Imfinzi Regimen Improves Survival With Manageable Side Effects in Liver Cancer Subset
Patients with HR+, HER2–, Early Breast Cancer Experienced Survival Improvement with Verzenio Plus Endocrine Therapy